Twelve emerging Israeli biotech and medical device companies will explore investment and partnering opportunities with Maryland firms at a conference at Johns Hopkins University next month, according to the nonprofit Maryland/Israeli Development Center.
At least 80 Maryland bioscience executives and researchers, venture capitalists and investors are expected to attend the fifth annual event.
Israeli firms include those developing a noninvasive blood pressure monitor, new approaches for tissue regeneration and repair, and devices to treat chronic head and neck pain. – Aaron Cahall
